Peroxisome proliferator-activated receptors and liver X receptors in atherosclerosis and immunity.

Grant D Barish

Journal: The Journal of nutrition 2006;136(3):690-4

PMID: 16484544

Free Full Text on Elsevier Science View on PubMed

Abstract

Atherosclerosis is a primary cause of death in the United States, and the current obesity epidemic threatens to exacerbate its morbidity and mortality worldwide. Despite important cardiovascular treatment advances over the past few decades, new approaches are needed to curb dangerous health trends. Nuclear receptors are a superfamily of ligand-activated transcription factors. The discovery of subfamilies known as peroxisome proliferator-activated receptors (PPAR) and liver X receptors (LXR) as lipid-sensors that regulate lipid and glucose metabolism as well as inflammation offers new targets for nutritional and pharmacologic treatment of cardiovascular disease.

Address: Gene Expression Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA. [email protected]

DOI: 10.1093/jn/136.3.690